San Diego-primarily based Viking Therapeutics marked itself as a significant competitor within the weight loss drug market in February right after revealing promising data from the mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when provided for a weekly injection As well as in March t